Diastolic Heart Failure: Clinical Trials

13 trials for Diastolic Heart Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 3 terminated, 2 withdrawn, 1 not yet recruiting. 13 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 213Completed 7, Terminated 3, Withdrawn 2, Not yet recruiting 1
Phase 12Completed 1, Withdrawn 1
Phase 32Completed 1, Terminated 1

Follow Diastolic Heart Failure: new trials by email Literature Review of Diastolic Heart Failure trials Research Report on Diastolic Heart Failure

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Bimagrumab in Participants With HFpEF
Bimagrumab, Placebo - Heart Failure, Diastolic, Diastolic Heart Failure
Phase 2Not yet recruitingEli Lilly and Company5402026-11-012026-11-06
Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES
Sulforaphane - Diastolic Dysfunction, Systolic Dysfunction
Phase 1 / Phase 2WithdrawnTexas Tech University Health Sciences Center2022-07-012026-06-29
Pharmacokinetics, Pharmacodynamics, and Impact of Inorganic Nitrate on Exercise in HFpEF
KNO3, KCl - Heart Failure, Diastolic Heart Failure
Phase 2CompletedUniversity of Pennsylvania122015-01-012017-10-03
If Channel Blockade With Ivabradine in Patients With Diastolic Heart Failure
Ivabradine, Placebo - Diastolic Heart Failure
Phase 2WithdrawnSt Vincent's University Hospital, Ireland2012-12-012014-11-25
Denervation of the renAl sympathetIc nerveS in hearT Failure With nOrmal Lv Ejection Fraction
renal denervation - Diastolic Heart Failure, Hypertension
Phase 2 / Phase 3TerminatedUMC Utrecht602012-04-012021-05-03
Ranolazine in Diastolic Heart Failure
Ranolazine, Saline 0.9% and placebo tablet - Diastolic Heart Failure
Phase 2CompletedGilead Sciences202010-04-012012-07-12
Metoprolol XR in Heart Failure With Normal Ejection Fraction
Metoprolol XR - Diastolic Heart Failure
Phase 2CompletedPost Graduate Institute of Medical Education and Research, Chandigarh1022010-01-012019-03-21
Perhexiline Therapy in Heart Failure With Preserved Ejection Fraction Syndrome
Perhexiline, Placebo - Diastolic Heart Failure
Phase 2CompletedUniversity of Aberdeen702009-03-012015-11-05
Beginning a Randomized Evaluation of the AGE Breaker Alagebrium in Diastolic Heart Failure (BREAK-DHF-I)
alagebrium, placebo - Diastolic Heart Failure
Phase 2TerminatedSynvista Therapeutics, Inc1602008-03-012009-01-30
A Randomized Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Effects of Alagebrium on Exercise in Subjects With Diastolic Heart Failure
Alagebrium - Diastolic Heart Failure
Phase 2TerminatedCardiovascular Clinical Sciences Inc1342007-12-012013-08-01
A Study of the Effectiveness of Sitaxsentan Sodium in Patients With Diastolic Heart Failure
Sitexsentin sodium, Placebo - Diastolic Heart Failure
Phase 2CompletedPfizer2002006-03-272023-01-04
Phosphodiesterase-5 (PDE5) Inhibition and Pulmonary Hypertension in Diastolic Heart Failure
Sildenafil, Placebo - Pulmonary Hypertension, Diastolic Heart Failure
Phase 2 / Phase 3CompletedUniversity of Milan442006-01-012012-06-15
Study of Nesiritide in Diastolic Heart Failure.
neseritide - Diastolic Heart Failure
Phase 1 / Phase 2CompletedMassachusetts General Hospital202002-12-012014-03-26

Narrower conditions

Heart Failure, Diastolic (13)  ·  Heart Failure (3)  ·  Coronary Artery Disease (1)  ·  Hypertension (1)  ·  Hypertension, Pulmonary (1)  ·  Sarcopenia (1)

Broader conditions

Cardiovascular Diseases (13)  ·  Heart Diseases (13)  ·  Heart Failure (10)  ·  Vascular Diseases (3)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Atrophy (1)  ·  Coronary Disease (1)  ·  Hypertension (1)  ·  Lung Diseases (1)  ·  Muscular Atrophy (1)  ·  Myocardial Ischemia (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Neuromuscular Manifestations (1)

Interventions

alagebrium (2)  ·  Ivabradine (1)  ·  Perhexiline (1)  ·  Potassium Chloride (1)  ·  Ranolazine (1)  ·  Saline Solution (1)  ·  Sildenafil Citrate (1)  ·  Sodium Chloride (1)  ·  bimagrumab (1)  ·  potassium nitrate (1)  ·  sulforaphane (1)

Sponsors

Cardiovascular Clinical Sciences Inc (1)  ·  Eli Lilly and Company (1)  ·  Gilead Sciences (1)  ·  Massachusetts General Hospital (1)  ·  Pfizer (1)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (1)  ·  St Vincent's University Hospital, Ireland (1)  ·  Synvista Therapeutics, Inc (1)  ·  Texas Tech University Health Sciences Center (1)  ·  UMC Utrecht (1)  ·  University of Aberdeen (1)  ·  University of Milan (1)  ·  University of Pennsylvania (1)

Countries

United States (5)  ·  Canada (1)  ·  Germany (1)  ·  Hungary (1)  ·  India (1)  ·  Ireland (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  United Kingdom (1)

Top investigators

Bertram Pitt, MD (1)  ·  Dermot J McCaffrey, MB MRCPI FRACP (1)  ·  Julio A Chirinos, MD (1)  ·  Lars S. Maier, MD (1)  ·  Marc J S, MD (1)  ·  Michael P Frenneaux, MBBS MD (1)  ·  Michiel Voskuil, MD, PhD (1)  ·  Samir Malhotra, MD, DM (1)

Results publications

PMID 21538388, PMID 21709061, PMID 23883653, PMID 24621836, PMID 24720918, PMID 25495811, PMID 27927683